Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammation

Inflammation

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Lipid Digestion

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

bioRxiv : the preprint server for biology·2026

Same author

<i>Ppm1d</i> Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Nature·2026

Same author

Impact of Breast Cancer on Ovarian Function: Dysregulation of Cholesterol Homeostasis in Cumulus Cells and Follicular Fluid.

Cancers·2026

Same author

Atherosclerosis Profiling Reveals BHLHE40 as a Candidate Modulator of VSMC.

Circulation research·2026

Same author

Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution.

bioRxiv : the preprint server for biology·2026

Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026

Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026

Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026

Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026

Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026

Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.

Sebastian Zimmer¹, Alena Grebe², Siril S Bakke³

¹Medizinische Klinik und Poliklinik II, University Hospital Bonn, 53105 Bonn, Germany.

Science Translational Medicine

|April 8, 2016

Summary

This summary is machine-generated.

The study found that 2-hydroxypropyl-β-cyclodextrin (CD) effectively reduces atherosclerosis by increasing cholesterol solubility. This compound promotes plaque regression and exerts anti-inflammatory effects, offering a potential clinical treatment for cardiovascular disease.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Related Experiment Videos

Last Updated: Mar 23, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Area of Science:

Cardiovascular Science
Inflammation Biology
Pharmacology

Background:

Atherosclerosis is a leading cause of global mortality, driven by chronic inflammation and cholesterol accumulation.
Current treatments for atherosclerosis face limitations despite advancements.
Retention of apolipoprotein B lipoproteins leads to free cholesterol overload and triggers inflammatory responses.

Purpose of the Study:

To investigate the efficacy of 2-hydroxypropyl-β-cyclodextrin (CD) in preventing and reversing atherosclerosis.
To elucidate the mechanisms underlying CD's effects on cholesterol metabolism and inflammation in atherosclerosis.

Main Methods:

Treatment of murine atherosclerosis models with CD.
Analysis of atherosclerotic plaque size, cholesterol crystal load, and inflammatory markers.
Investigation of oxysterol production and liver X receptor (LXR) activation.
Assessment of cholesterol efflux and reverse cholesterol transport.

Main Results:

CD treatment significantly reduced atherosclerotic plaque size and cholesterol crystal burden in mice.
CD promoted plaque regression even under a cholesterol-rich diet.
Mechanistically, CD enhanced oxysterol production and LXR-mediated cholesterol efflux, leading to anti-inflammatory effects.
CD-induced LXR agonism was crucial for its anti-atherosclerotic and anti-inflammatory actions.

Conclusions:

2-hydroxypropyl-β-cyclodextrin (CD) demonstrates significant potential in preventing and reversing atherosclerosis.
CD's therapeutic effects are mediated by enhanced cholesterol efflux and LXR activation.
CD's established safety profile in humans suggests its clinical utility for treating atherosclerosis and cardiovascular disease.